Public signal · 1-minute delayed

Signal brief

Source-backed market context you can read and share without an account.

Browse signals

CUEBullishAnalyst Target Updateanalyst

High materiality7/10

B.Riley Reiterates Buy Rating on Cue Biopharma (CUE)

Oct 1, 2026, 8:03 AM EDT1 sourcesAI-analyzed

Why it may matterVerify against the original reporting

bullish

AI summary

What happened, with direct paths to the underlying reporting

B.Riley reiterates Buy on CUE. Target 83; posted price 25.87.

Buy reiterated; target 83 vs 25.87

Key facts

01
Target: $83
02
Posted price: $25.87
03
Analyst firm: B.Riley Financial
04
Analyst: Mayank Mamtani

How to read this signal

Transparent limits for an AI-generated research aid

StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.